Please assess the completion status of the following clinical trial:

Trial Title: Effects of Omega-3 Fatty Acid Supplementation in Acne Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female above 18 years of age.~* Moderate to severe disease at the baseline of the study identified by their dermatologist.~* Will start treatment with systemic therapy for acne in the form of either isotretinoin or oral antibiotics.~* Patients able and willing to comply with the procedures in the study protocol.~Exclusion Criteria:~* Patients with history of taking omega-3 supplements for high triglyceride levels.~* Patients taking medications for dyslipidemia, blood thinners, or high blood pressure medication.~* Patients with a history of adverse reaction to omega-3 fatty acid supplementation.~* Unwilling to give inform consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- O3FA (Type: EXPERIMENTAL): Omega 3 Fatty Acid 1200mg twice a day for 24 weeks
- Placebo (Type: PLACEBO_COMPARATOR): 4 tablets twice a day for 24 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).